IL-6 is required for the development of Th1 cell-mediated murine colitis

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4878-4882

  Yamamoto, Mitsunari ^a   Yoshizaki, Kazuyuki ^b   Kishimoto, Tadamitsu ^b   Ito, Hiroaki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; T LYMPHOCYTE ACTIVATION; TH1 CELL; WASTING SYNDROME;

EID: 0034193039     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4878     Document Type: Article

References (20)

1. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J. Immunol. 157:1261.
2. Olaison, B., R. Sjodahl, and C. Tagesson. 1990. Glucocorticoid treatment in ileal Crohn's disease. Gut 31:325.
3. Willoughby, J. M., P. J. Kumar, J. Beckett, and A. M. Dawson. 1971. Controlled trial of azathioprine in Crohn's disease. Lancet 2:944.
4. Baert, F. J., G. R. D'Haens, M. Peeters, M. I. Hiele, T. F. Schaible, D. Shealy, K. Geboes, and P. J. Rutgeerts. 1999. Tumor necrosis factor α antibody (Infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 116:22.
5. Gross, V., T. Andus, I. Caesar, M. Roth, and J. Scholmerich. 1992. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 102:514.
6. Mitsuyama, K., A. Toyonaga, E. Sasaki, O. Ishida, H. Ikeda, O. Tsuruta, K. Harada, H. Tateishi, T. Nishiyama, and K. Tanikawa. 1995. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 36:45.
7. Kishimoto, T., S. Akira, and T. Taga. 1992. Interleukin-6 and its receptor: a paradigm for cytokines. Science 258:593.
8. Romano, M., M. Sironi, C. Toniatti, N. Polentarutti, P. Fruscella, P. Ghezzi, R. Faggioni, W. Luini, V. Van Hinsbergh, S. Sozzani, et al. 1997. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6:315.
9. + T cells. Immunity 1:553.
10. Neurath, M., I. Fuss, B. L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281.
11. + T cells. J. Exp. Med. 183:2669.
12. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
13. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1.
14. Ohshima, S., Y. Saeki, T. Mima, M. Sasai, K. Nishioka, S. Nomura, M. Kopf, Y. Katada, T. Tanaka, M. Suemura, and T. Kishimoto. 1998. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. USA 95:8222.
15. Samoilova, E. B., J. L. Horton, B. Milliard, T. S. T. Liu, and Y. Chen. 1998. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:6480.
16. Koizumi, M., N. King, R. Lobb, C. Benjamin, and D. K. Podolsky. 1992. Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 103:840.
17. Nakamura, S., H. Ohtani, Y. Watanabe, K. Fukushima, T. Matsumoto, A. Kitano, K. Kobayashi, and H. Nagura. 1993. In situ expression of the cell adhesion molecules in inflammatory bowel disease: evidence of immunologic activation of vascular endothelial cells. Lab. Invest. 69:77.
18. Kelsall, B. L., E. Stuber, M. Neurath, and W. Strober. 1996. Interleukin-12 production by dendritic cells: the role of CD40-CD40L interactions in Th1 T-cell responses. Ann. NY Acad. Sci. 795:116.
19. Déchanet, J., C. Grosset, J. L. Taupin, P. Merville, J. Banchereau, J. Ripoche, and J. F. Moreau. 1997. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. J. Immunol. 159:5640.
20. Stuber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40-CD40L interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693.